These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 34811506

  • 1. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Ramirez-Garrastacho M, Berge V, Linē A, Llorente A.
    Br J Cancer; 2022 Feb; 126(3):492-501. PubMed ID: 34811506
    [Abstract] [Full Text] [Related]

  • 2. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L.
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [Abstract] [Full Text] [Related]

  • 3. Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.
    Koppers-Lalic D, Hackenberg M, de Menezes R, Misovic B, Wachalska M, Geldof A, Zini N, de Reijke T, Wurdinger T, Vis A, van Moorselaar J, Pegtel M, Bijnsdorp I.
    Oncotarget; 2016 Apr 19; 7(16):22566-78. PubMed ID: 26992225
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S, Meschkat P, Edelmann P, Heinzelmann J, Pryalukhin A, Bohle R, Heinzelbecker J, Stöckle M, Junker K.
    J Cancer Res Clin Oncol; 2019 Nov 19; 145(11):2725-2736. PubMed ID: 31552489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Fredsøe J, Rasmussen AKI, Mouritzen P, Borre M, Ørntoft T, Sørensen KD.
    Int J Cancer; 2019 Nov 01; 145(9):2558-2567. PubMed ID: 30903800
    [Abstract] [Full Text] [Related]

  • 10. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K, Daniūnaitė K, Jankevičius F, Jarmalaitė S.
    Medicina (Kaunas); 2016 Nov 01; 52(2):116-24. PubMed ID: 27170485
    [Abstract] [Full Text] [Related]

  • 11. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
    Zottel A, Šamec N, Kump A, Raspor Dall'Olio LR, Pužar Dominkuš P, Romih R, Hudoklin S, Mlakar J, Nikitin D, Sorokin M, Buzdin A, Jovčevska I, Komel R.
    Int J Mol Sci; 2020 Nov 11; 21(22):. PubMed ID: 33187334
    [Abstract] [Full Text] [Related]

  • 12. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 11; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
    O'Farrell HE, Bowman RV, Fong KM, Yang IA.
    Int J Mol Sci; 2021 May 28; 22(11):. PubMed ID: 34071592
    [Abstract] [Full Text] [Related]

  • 15. Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma.
    Di Paolo V, Paolini A, Galardi A, Gasparini P, De Cecco L, Colletti M, Lampis S, Raieli S, De Stefanis C, Miele E, Russo I, Di Ruscio V, Casanova M, Alaggio R, Masotti A, Milano GM, Locatelli F, Di Giannatale A.
    J Exp Clin Cancer Res; 2024 Oct 09; 43(1):282. PubMed ID: 39385294
    [Abstract] [Full Text] [Related]

  • 16. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A.
    Prostate; 2016 Jan 09; 76(1):68-79. PubMed ID: 26417675
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J, Rasmussen AKI, Thomsen AR, Mouritzen P, Høyer S, Borre M, Ørntoft TF, Sørensen KD.
    Eur Urol Focus; 2018 Dec 09; 4(6):825-833. PubMed ID: 28753866
    [Abstract] [Full Text] [Related]

  • 18. Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression.
    Lekchnov EA, Amelina EV, Bryzgunova OE, Zaporozhchenko IA, Konoshenko MY, Yarmoschuk SV, Murashov IS, Pashkovskaya OA, Gorizkii AM, Zheravin AA, Laktionov PP.
    Int J Mol Sci; 2018 Dec 17; 19(12):. PubMed ID: 30562989
    [Abstract] [Full Text] [Related]

  • 19. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
    Rana S, Valbuena GN, Curry E, Bevan CL, Keun HC.
    Br J Cancer; 2022 Feb 17; 126(3):502-513. PubMed ID: 35022525
    [Abstract] [Full Text] [Related]

  • 20. Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer.
    Wang Y, Fang YX, Dong B, Du X, Wang J, Wang X, Gao WQ, Xue W.
    Theranostics; 2021 Feb 17; 11(2):878-892. PubMed ID: 33391510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.